You are here: Home » Current Affairs » Coronavirus » News
Business Standard

For now, Covid vaccine recipients will not get to choose from 2 options

The government hinted that for now, the Covid vaccine recipients will not have the option to choose from the two vaccines approved for restricted emergency use

Coronavirus Vaccine | Coronavirus | Coronavirus Tests

Press Trust of India  |  New Delhi 

Coronavirus, vaccine, covid, drugs, clinical trials
Representational image of a Covid-19 vaccine

The government hinted on Tuesday that for now, the COVID vaccine recipients will not have the option to choose from the two vaccines recently approved for restricted emergency use in India.

Replying to a question at a press conference here, Union Health Secretary Rajesh Bhushan said, "At many places in the world, more than one vaccine are being administered, but presently, in no country, vaccine recipients have the option of choosing the shots."

India has recently approved two vaccines for the viral disease for restricted emergency use -- Oxford University's Covishield and Bharat Biotech's Covaxin.

Bhushan said there will be a gap of 28 days between two doses of the COVID-19 vaccine and its effectiveness can be seen only after 14 days.

"So we urge people to keep following COVID appropriate behaviour," he said.

India will launch its COVID-19 vaccination drive from January 16 with priority to be given to nearly three crore healthcare and frontline workers.

Bhushan said 54.72 lakh of the entire stock of COVID-19 vaccine doses ordered so far were received by the designated national and state-level vaccine stores till Tuesday afternoon, with the inoculation drive set to begin from Saturday.

He said all the orders -- 1.1 crore doses of Covishield from the Serum Institute of India and 55 lakh doses of Covaxin from -- will be received by January 14.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, January 12 2021. 20:29 IST